{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:10:26Z","timestamp":1785168626367,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011039","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000}}],"reference-count":86,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011039.pub2","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T12:21:44Z","timestamp":1705580504000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome"],"prefix":"10.1002","volume":"2024","author":[{"given":"Alejandro G","family":"Gonzalez-Garay","sequence":"additional","affiliation":[{"name":"Research Methodology Department; Instituto Nacional de Pediatr\u00eda; Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora E","family":"Serralde-Z\u00fa\u00f1iga","sequence":"additional","affiliation":[{"name":"Clinical Nutrition Service; Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n; Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Velasco Hidalgo","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Department; Instituto Nacional de Pediatr\u00eda; Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayelli Cointa","family":"Flores Garc\u00eda","sequence":"additional","affiliation":[{"name":"Gastroenterology Department; Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n; Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma. Isabel","family":"Aguirre-Salgado","sequence":"additional","affiliation":[{"name":"Medical Library; Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n; Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD011039.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Gin\u00e8s","year":"2002","journal-title":"Gastroenterology"},{"issue":"23","key":"10.1002\/14651858.CD011039.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","article-title":"A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites","volume":"342","author":"R\u00f6ssle","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"S3","key":"10.1002\/14651858.CD011039.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/jgh.12766_2","article-title":"Does transjugular intrahepatic portosystemic shunt (TIPS) with covered stents modify the natural course of decompensed cirrhosis?","volume":"29","author":"Adhoute","year":"2014","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"334A","DOI":"10.1002\/hep.27493","article-title":"Does transjugular intrahepatic portosystemic shunt (TIPS) with covered stents modify the natural course of decompensed cirrhosis?","volume":"60","author":"Adhoute","year":"2014","journal-title":"Hepatology"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD011039.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"A1024","DOI":"10.1016\/0016-5085(95)28397-8","article-title":"Treatment of hepatorenal syndrome with the transjugular intrahepatic portosystemic shunt (TIPS)","volume":"108","author":"Alam","year":"1995","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD011039.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1097\/MEG.0b013e32832ec16a","article-title":"Degree of hepatic dysfunction and improvement of renal function predict survival in patients with HRS type I: a retrospective analysis","volume":"21","author":"Appenrodt","year":"2009","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"9053","key":"10.1002\/14651858.CD011039.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/s0140-6736(97)24010-9","article-title":"Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome","volume":"349","author":"Brensing","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD011039.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"issue":"11","key":"10.1002\/14651858.CD011039.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1007\/s10620-020-06136-2","article-title":"Inpatient mortality benefit with transjugular intrahepatic portosystemic shunt for hospitalized hepatorenal syndrome patients","volume":"65","author":"Charilaou","year":"2020","journal-title":"Digestive Diseases and Sciences"},{"issue":"6","key":"10.1002\/14651858.CD011039.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1080\/003655200750023642","article-title":"Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: effects in patients with organic or functional renal failure","volume":"35","author":"Michl","year":"2000","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0011|cit11","unstructured":"TIPS with coated stents for refractory ascites in patients with cirrhosis clinicaltrials.gov\/ct2\/show\/NCT00222014"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0012|cit12","unstructured":"Comparing ascites relief in two standard treatments: large volume paracentesis vs. early TIPS using Viatorr controlled expansion stents clinicaltrials.gov\/ct2\/show\/NCT04315571"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD011039.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.1016\/j.jvir.2015.12.496","article-title":"Reduced inpatient mortality with transjugular intrahepatic portosystemic shunt (TIPS) creation in cirrhotic patients admitted with hepatorenal syndrome","volume":"27","author":"Trivedi","year":"2016","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD011039.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"S124","DOI":"10.1016\/j.jvir.2018.12.340","article-title":"Sex disparity in survival following transjugular intrahepatic portosystemic shunt creation in patients with hepatorenal syndrome","volume":"30","author":"Trivedi","year":"2019","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"2","key":"10.1002\/14651858.CD011039.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jacr.2019.08.020","article-title":"Gender disparity in inpatient mortality after transjugular intrahepatic portosystemic shunt creation in patients admitted with hepatorenal syndrome: a nationwide study","volume":"17","author":"Trivedi","year":"2020","journal-title":"Journal of the American College of Radiology"},{"issue":"1","key":"10.1002\/14651858.CD011039.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0017|cit17","unstructured":"Junge G Schewior L Neuhaus P Hepatorenal syndrome in patients waiting for LTx \u2013 efficacy of different plasma volume expansion\/vasoconstriction regimens compared to TIPS Liver Transplantation 2010 16 1 S81 10.1002\/lt.22086."},{"key":"10.1002\/14651858.CD011039.pub2-BIB0018|cit18","unstructured":"Schewior L Frei U Neuhaus P Junge G Treatment and impact of hepatorenal syndrome for patients on waiting list for liver transplantation Liver Transplantation 2008 14 S1 S219 20 10.1002\/lt.21569"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0019|cit19","unstructured":"HRS-AKI treatment with TIPS in patients with cirrhosis (Liver-HERO) clinicaltrials.gov\/ct2\/show\/NCT05346393"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13063-023-07261-9","article-title":"Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis\u2014a randomized controlled trial","volume":"24","author":"Ripoll","year":"2023","journal-title":"Trials"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.jhep.2005.06.005","article-title":"A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites","volume":"43","author":"Albillos","year":"2005","journal-title":"Journal of Hepatology"},{"issue":"12","key":"10.1002\/14651858.CD011039.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/00042737-200212000-00013","article-title":"Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2","volume":"14","author":"Alessandria","year":"2002","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"International Club of Ascites. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD011039.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1055\/s-2008-1040323.","article-title":"Pathogenesis and treatment of hepatorenal syndrome","volume":"28","author":"Arroyo","year":"2008","journal-title":"Seminars in Liver Disease"},{"issue":"10","key":"10.1002\/14651858.CD011039.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.3748\/wjg.v20.i10.2704","article-title":"TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis","volume":"20","author":"Bai","year":"2014","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/17562848221102679","article-title":"Management of hepatorenal syndrome in liver cirrhosis: a recent update","volume":"15","author":"Bera","year":"2022","journal-title":"Therapeutic advances in gastroenterology"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0027|cit27","unstructured":"Boutron I Page MJ Higgins JP Altman DG Lundh A Hr\u00f3bjartsson A Chapter 7: Considering bias and conflicts of interest among the included studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"2","key":"10.1002\/14651858.CD011039.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"4","author":"Brensing","year":"2000","journal-title":"Gut"},{"issue":"8","key":"10.1002\/14651858.CD011039.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD011039.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive \u2013 trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD011039.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1665-2681(19)32154-4","article-title":"Hepatorenal syndrome","volume":"2","author":"C\u00e1rdenas","year":"2003","journal-title":"Annals of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD011039.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/ndt\/gfr736","article-title":"Medical management of hepatorenal syndrome","volume":"27","author":"Davenport","year":"2012","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0033|cit33","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"3","key":"10.1002\/14651858.CD011039.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods of combining randomised clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011039.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"2","key":"10.1002\/14651858.CD011039.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study","volume":"36","author":"Duvoux","year":"2002","journal-title":"Hepatology"},{"issue":"7109","key":"10.1002\/14651858.CD011039.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"1","key":"10.1002\/14651858.CD011039.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7010","article-title":"How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study","volume":"7","author":"Egger","year":"2003","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0039|cit39","unstructured":"EndNote 21 Clarivate Analytics 2023"},{"issue":"3","key":"10.1002\/14651858.CD011039.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/hep.510280313","article-title":"Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites or without ascites","volume":"28","author":"Gerbes","year":"1998","journal-title":"Hepatology"},{"issue":"9398","key":"10.1002\/14651858.CD011039.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","author":"Gin\u00e8s","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD011039.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/hep.23286","article-title":"Systematic review of randomised trials on vasoconstrictor drugs for hepatorenal syndrome","volume":"51","author":"Gluud","year":"2010","journal-title":"Hepatology"},{"issue":"9","key":"10.1002\/14651858.CD011039.pub2-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005162.pub3","article-title":"Terlipressin for hepatorenal syndrome","author":"Gluud","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0044|cit44","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"issue":"2","key":"10.1002\/14651858.CD011039.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"issue":"9","key":"10.1002\/14651858.CD011039.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1517\/14656566.2011.561200","article-title":"Hepatorenal syndrome","volume":"12","author":"Guevara","year":"2011","journal-title":"Expert Opinion in Pharmacotherapy"},{"issue":"7650","key":"10.1002\/14651858.CD011039.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"20","key":"10.1002\/14651858.CD011039.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011039.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1478-3231.2011.02586.x","article-title":"New insights into the management of hepatorenal syndrome","volume":"31","author":"Hasper","year":"2011","journal-title":"Liver International"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0050|cit50","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0051|cit51","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page M Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0052|cit52","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey on published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0054|cit54","unstructured":"International Council for Harmonisation of technical requirements for pharmaceuticals for human use (ICH) ICH Harmonised Guideline. Integrated addendum to ICH E6(R1): guideline for good clinical practice E6(R2) database.ich.org\/sites\/default\/files\/E6_R2_Addendum.pdf"},{"issue":"1","key":"10.1002\/14651858.CD011039.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002147","article-title":"Terlipressin for acute oesophageal variceal haemorrhage","author":"Ioannou","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"11","key":"10.1002\/14651858.CD011039.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00042737-199611000-00015","article-title":"Mechanisms of changes in renal handling of sodium following transjugular intrahepatic portal systemic stent-shunt (TIPSS)","volume":"8","author":"Jalan","year":"1996","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD011039.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011039.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1001\/jama.289.2.217","article-title":"Artificial and bio artificial support systems for acute and acute-on-chronic liver failure: a systematic review","volume":"289","author":"Kjaergard","year":"2003","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD011039.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analyses","volume":"20","author":"Macaskill","year":"2001","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0061|cit61","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0062|cit62","first-page":"n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0063|cit63","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0064|cit64","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2023"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1136\/gut.2009.193227","article-title":"TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update","volume":"59","author":"R\u00f6ssle","year":"2010","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD011039.pub2-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004889.pub2","article-title":"TIPS versus paracentesis for cirrhotic patients with refractory ascites","author":"Saab","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011039.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1053\/j.gastro.2007.06.020","article-title":"Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data","volume":"133","author":"Salerno","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0068|cit68","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"7","key":"10.1002\/14651858.CD011039.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/MCG.0b013e318188947c","article-title":"Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome","volume":"43","author":"Skagen","year":"2009","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD011039.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.gastro.2007.10.055","article-title":"Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis","volume":"134","author":"Stadlbauer","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0071|cit71","first-page":"l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"54","key":"10.1002\/14651858.CD011039.pub2-BIB0072|cit72","first-page":"1753","article-title":"Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation","volume":"50","author":"Testino","year":"2003","journal-title":"Hepato-Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD011039.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0074|cit74","first-page":"57","article-title":"Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals","volume":"2","author":"Thorlund","year":"2010","journal-title":"Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0075|cit75","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User Manual for Trial Sequential Analysis (TSA); 2nd edition. Copenhagen Trial Unit, 2017 Available from ctu.dk\/tsa\/learn-more"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0076|cit76","unstructured":"TSA \u2013 Trial Sequential Analysis Copenhagen Trial Unit 2021"},{"issue":"1","key":"10.1002\/14651858.CD011039.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1055\/s-0032-1301735","article-title":"Hepatorenal syndrome: a critical update","volume":"33","author":"Wadei","year":"2012","journal-title":"Seminars in Respiratory and Critical Care Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011039.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40265-018-1018-z","article-title":"Hepatic encephalopathy: definition, clinical grading and diagnostic principles","volume":"79","author":"Weissenborn","year":"2019","journal-title":"Drugs"},{"issue":"1","key":"10.1002\/14651858.CD011039.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD011039.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Medical Research Methodology"},{"issue":"4","key":"10.1002\/14651858.CD011039.pub2-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007339.pub2","article-title":"Pentoxifylline for alcoholic hepatitis","author":"Whitfield","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD011039.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"816","DOI":"10.7326\/0003-4819-122-11-199506010-00002","article-title":"Transjugular intrahepatic portosystemic stent shunt: effects on haemodynamics and sodium homeostasis in cirrhosis and refractory ascites","volume":"122","author":"Wong","year":"1995","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011039.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011039.pub2-BIB0085|cit85","unstructured":"High income data data.worldbank.org\/country\/XD"},{"issue":"3","key":"10.1002\/14651858.CD011039.pub2-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011039","article-title":"Transjugular intrahepatic portosystemic shunts for hepatorenal syndrome","author":"Hinojosa-Azaola","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T01:32:09Z","timestamp":1734917529000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011039.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011039.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]}}}